POLYPEPTIDE-BASED NANOHYBRID LIPOSOMAL NANO PARTICLES TO ENHANCE THE ANTI-ANGIOGENESIS AND ANTI-TUMOR RESPONSE OF AXITINIB
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: TAK, Jin Wook (Yeungnam University, Daegu, South-Korea)
- Co-author(s): Yong, Joo Choi (, South-Korea)
Axitinib (AXT) is a potent and selective inhibitor of vascular endothelial growth factor receptors 1–3 that contribute to the pathogenesis of solid tumours.
AXT-loaded polypeptide-based hybrid liposomal nanoparticles (P-LNP/AXT)was fabricated, and evaluated for physicochemical properties,in vitro and in vivo antitumor activity.
P-LNP/AXT with a mean.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.